The global Gabapentin Market was valued at US$ 2,145.3 million in 2024 and is projected to reach US$ 3,875.6 million by 2032, reflecting a CAGR of 7.6% during the forecast period (2024-2032). Historically, the market stood at US$ 1,586.6 million in 2022, showcasing steady growth driven by increased diagnoses of neurological conditions and expanding applications of Gabapentin. Gabapentin is a pha..
